Discover how Agilent LC/MS solutions can accurately detect, identify and quantify nitrosamines in APIs and drug products

Recently, the U.S. Food and Drug Administration found nitrosamines impurities in several ranitidine and sartan-based drugs, resulting in widespread recall of these drugs.

Several LC/MS based approaches have since been published to provide options for regulators and industries to detect nitrosamine impurities in ranitidine and sartan drug substances and drug products.

Chat zalo
Chat messenger
Liên hệ chúng tôi